It’s been a good week for Eli Lilly and Company (NYSE:LLY) shareholders, because the company has just released its latest first-quarter results, and the shares gained 6.1% to US$777. Eli Lilly reported in line with analyst predictions, delivering revenues of US$8.8b and statutory earnings per share of US$2.48, suggesting the business is executing well and in line with its plan. Earnings are an important time for investors, as they can track a company’s performance, look at what the analysts are forecasting for next year, and see if there’s been a change in sentiment towards the company. We’ve gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
View our latest analysis for Eli Lilly
Taking into account the latest results, the consensus forecast from Eli Lilly’s 27 analysts is for revenues of US$43.2b in 2024. This reflects a…
